Tower Research Capital LLC (Trc) Vascular Biogenics Ltd. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.15 - $2.1 $140 - $1,967	937 New	937 $0
Q1 2022 May 12, 2022	SELL	$1.15 - $1.97 $1,150 - $1,970	-1,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.92 - $2.53 $1,920 - $2,530	1,000 New	1,000 $2,000
Q4 2018 Feb 14, 2019	SELL	$0.6 - $1.72 $1,083 - $3,104	-1,805 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$1.55 - $2.17 $2,015 - $2,821	1,300 Added 257.43%	1,805 $3,000
Q2 2018 Aug 15, 2018	SELL	$2.05 - $3.0 $1,289 - $1,887	-629 Reduced 55.47%	505 $1,000
Q1 2018 May 15, 2018	BUY	$2.27 - $8.5 $2,574 - $9,639	1,134 New	1,134 $3,000
Q4 2017 Feb 09, 2018	SELL	$5.65 - $9.0 $10,062 - $16,029	-1,781 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.15 - $7.2 $7,391 - $12,823	1,781	1,781 $11,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.